In 2023, South Korea led global hospital discharges for carcinoma in situ with 56.1 per hundred thousand persons, a notable 7.49% increase. The Netherlands follows with a marginal rise, while Poland also saw a significant 7.16% gain. Chile remained stable, whereas Italy and Ireland faced slight declines. Over the past five years, varying growth rates indicate regional divergences, with South Korea consistently outpacing others in discharge volumes.
Future trends to monitor include technological advancements in early detection, shifts in healthcare policy, and public health campaigns that may influence discharge rates. There might be investment in healthcare infrastructure impacting capacity and reporting accuracy globally.
Top countries in Hospital Discharges for Carcinoma in Situ by Country
| # | 10 Countries | Units (Hospital Discharges) Per Hundred Thousand Persons | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Korea | 56.1 | 2023 | +6.65% | +7.49% | View data |
| 2 | 2 Netherlands | 42.3 | 2023 | +1.44% | +0.53% | View data |
| 3 | 3 Spain | 23.8 | 2023 | +4.39% | +2.73% | View data |
| 4 | 4 Czech Republic | 15.9 | 2023 | +4.61% | +3.64% | View data |
| 5 | 5 Chile | 14.2 | 2023 | +5.19% | 0% | View data |
| 6 | 6 Israel | 13.5 | 2023 | +3.05% | +0.15% | View data |
| 7 | 7 Italy | 12.7 | 2023 | 0% | -0.77% | View data |
| 8 | 8 Ireland | 10.9 | 2023 | +7.92% | -0.89% | View data |
| 9 | 9 Poland | 10.6 | 2023 | +6% | +7.16% | View data |
| 10 | 10 Hungary | 8 | 2023 | +5.26% | +2.13% | View data |
